Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
City of Hope Medical Center
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
City of Hope Medical Center
Thomas Jefferson University
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
University College, London
Emory University
Northwestern University
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
Stanford University
University of Nebraska
Stanford University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Northwestern University
Northwestern University
Roswell Park Cancer Institute
Rochester General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Mayo Clinic
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center